NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine
India’s pharmaceutical pricing regulator has allowed a one-time price hike of 50 per cent for three key drugs
Read moreIndia’s pharmaceutical pricing regulator has allowed a one-time price hike of 50 per cent for three key drugs
Read moreIndian technology major Tata Consultancy Services (TCS) and pharmaceutical and biotech major Wockhardt are among the big
Read morePrivate equity firm Carlyle Group and Brighton Park Capital are investing $200 million in Indegene, the Bengaluru-headquartered
Read moreThe Indian pharma industry has risen to the occasion and has made efforts to ensure that medicines
Read morePfizer posted a profit before tax of Rs 173.3 crore for the June quarter of FY21, a negligible
Read more